ALLEGRI, Franca
 Distribuzione geografica
Continente #
EU - Europa 2.170
NA - Nord America 1.983
AS - Asia 873
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
OC - Oceania 1
Totale 5.031
Nazione #
US - Stati Uniti d'America 1.944
CN - Cina 716
IE - Irlanda 391
FI - Finlandia 387
IT - Italia 376
SE - Svezia 330
UA - Ucraina 300
DE - Germania 200
TR - Turchia 73
FR - Francia 72
SG - Singapore 71
GB - Regno Unito 52
CA - Canada 38
AT - Austria 19
BE - Belgio 18
RO - Romania 11
IN - India 6
CZ - Repubblica Ceca 5
NL - Olanda 3
VN - Vietnam 3
BD - Bangladesh 2
EU - Europa 2
PL - Polonia 2
RS - Serbia 2
AU - Australia 1
BR - Brasile 1
CL - Cile 1
ES - Italia 1
HK - Hong Kong 1
IR - Iran 1
MX - Messico 1
RU - Federazione Russa 1
Totale 5.031
Città #
Dublin 391
Chandler 375
Jacksonville 319
Dearborn 164
Nanjing 143
Beijing 135
Ashburn 113
Ann Arbor 111
Parma 98
Princeton 80
Izmir 72
San Mateo 50
Jinan 49
Nanchang 45
Shanghai 45
Wilmington 40
Shenyang 39
Singapore 38
Hebei 36
Boardman 35
Toronto 35
Bremen 33
Des Moines 31
Helsinki 26
Kunming 25
Changsha 24
Woodbridge 24
Collecchio 22
New York 22
Hefei 20
Jiaxing 20
Seattle 20
Milan 19
Rome 19
Vienna 19
Brussels 18
Zhengzhou 16
Grafing 15
Tianjin 14
Horia 11
Düsseldorf 10
Ningbo 10
Guangzhou 9
Hangzhou 9
Haikou 8
Taizhou 8
Auburn Hills 7
Chengdu 7
Los Angeles 7
Norwalk 7
Munich 6
Solignano 6
Carpi 5
Lanzhou 5
Torino 5
Wuhan 5
Bergamo 4
Brno 4
Florence 4
Fremont 4
Fuzhou 4
Houston 4
Naples 4
Pune 4
Redwood City 4
Turin 4
Baotou 3
Borås 3
Empoli 3
Lamezia Terme 3
Napoli 3
Piadena 3
Shaoxing 3
Taiyuan 3
Udine 3
Abbiategrasso 2
Ancona 2
Asti 2
Bareggio 2
Bernate Ticino 2
Bologna 2
Brescia 2
Cagliari 2
Chongqing 2
Cirimido 2
Cremona 2
Dong Ket 2
Frankfurt am Main 2
Godiasco 2
London 2
Lunano 2
Madison 2
Phoenix 2
Piombino 2
Redmond 2
Rockville 2
San Genesio Ed Uniti 2
Sant'Anastasia 2
Sant'Egidio del Monte Albino 2
Sesto Fiorentino 2
Totale 3.042
Nome #
Ipercalciuria idiopatica: confronto tra dieta ipocalcica e dieta iposodica-ipoproteica-normocalcica 199
Ipercalciuria idiopatica: confronto tra dieta ipocalcica e dieta iposodica-ipoproteica-normocalcica 140
Idiopathic calcium nephrolithiasis and 25-OH vitamin deficiency: new scenarios ? 121
Family history influences clinical course of idiopathic calcium nephrolithiasis: case-control study of a large cohort of Italian patients 106
Exploring the efficacy of indapamide therapy in preventing idiopathic calcium nephrolithiasis recurrence: a 25-year retrospective study 104
Understanding the gut-kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers 100
Idiopathic Calcium Nephrolithiasis and Hypovitaminosis D: a Case-Control Study 94
Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment 90
Different effects of lean and fat mass on urinary stone risk factors and on bone mineral density in healthy women. 89
Insights about urinary hippuric and citric acid as biomarkers of fruit and vegetable intake in patients with kidney stones: The role of age and sex 87
Come prevenire i calcoli renali 82
A simple quantitative test for screening cystinuria 82
Low potassium diet as a stone risk factor 82
La terapia idropinica è veramente utile nella calcolosi renale da ossalto di calcio? 80
Nefrolitiasi: prevenzione dell'ipercalciuria idiopatica 78
Allopurinol and indapamide in recurrent calcium and nephrolithiasis with hyperuricosuria and hypercalciuria 78
Dietary habits in women with recurrent idiopathic calcium nephrolithiasis. 78
Calcium oxalate crystallization in untreated urine, centrifuged and filtered urine and ultrafiltered urine 76
Indapamide therapy and hypercalciuric idiopathic calcium nephrolithiasis recurrences 75
Copy-number disorders are a common cause of congenital kidney malformations. 73
Influence of lean and fat mass on bone mineral density and on urinary stone risk factors in healthy women. 71
Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria 70
A diet to reduce mild hyperoxaluria in idiopathic calcium oxalate stone formers: a pilot study. 70
Decreased Transcriptional Activity ofCalcium-sensing receptorGene Promoter 1 Is Associated With Calcium Nephrolithiasis 70
The influence of maternal and paternal history on stone composition and clinical course of calcium nephrolithiasis in subjects aged between 15 and 25 70
Aggregazione cristallina in vitro: interazione tra macromolecole urinarie e ambiente macromolecolare 69
Nutritional aspects in primary hypercalciuria 69
Aggregazione cristallina in vitro: interazione tra macromolecole urinarie e ambiente macromolecolare 69
Vitamin D status in patients with idiopathic calcium nephrolithiasis 67
Body weight, diet and water intake in preventing stone disease 67
Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers 67
Calcium kidney stones are associated with a haplotype of the Calcium-sensing receptor gene regulatory region. 67
Effect of oligomineral water with low sodium and calcium content on urinary parameters of lithogenic risk in patients with kidney stones and high urinary calcium excretion: a pilot study 66
Essential arterial hypertension and stone disease 64
Hippuric acid in 24 h urine collections as a biomarker of fruits and vegetables intake in kidney stone formers 63
Diet to reduce mild hyperoxaluria in patients with idiopathic oxalate stone formation: a pilot study 62
The effect of fruits and vegetables on urinary stone risk factors 59
Una dieta per ridurre l’iperossaluria moderata in pazienti con nefrolitiasi calcica idiopatica: studio pilota 58
Determinants of calcium and oxalate excretion in subjects with calcium nephrolithiasis: the role of metabolic syndrome traits 58
Twenty-five years of idiopathic calcium nephrolithiasis: has anything changed? 57
A diet to reduce mild hyperoxaluria in idiopathic calcium oxalate stone formers: a pilot study. 57
Dietary treatment of nephrolithiasis. 57
Medical treatment of nephrolithiasis 57
Prevention of idiopathic hypercalciuria 57
Low sodium diet plus hydropinic therapy in idiopathic hypercalciuria 57
Allopurinol and indapamide in recurrent calcium and nephrolithiasis with hyperuricosuria and hypercalciuria. 56
Concentrated urine and diluted urine: the effects of citrate and magnesium onthe crystallization of calcium oxalate induced in vitro by an oxalate load 55
Calcium urolithiasis course in young stone formers is influenced by the strength of family history: results from a retrospective study 55
Withdrawal of sodium chloride from the table of calcium oxalate stone formers with idiopathic hypercalciuria: a three-month randomized controlled trial. 52
Hypercalciuria: low calcium diet in comparison with low sodium-low proteins-normal calcium diet 51
Urine volume: stone risk factor and preventive measure 51
Polimorfismo genetico del calcium-sensing receptor e calcolosi renale nell’iperparatiroidismo primitivo. 51
Effects of urine dilution on quantity, size and aggregation of calcium oxalatecrystals induced in vitro by an oxalate load. 51
Effetti della composizione corporea sulla densità ossea in donne sane e in donne con calcolosi calcica idiopatica. 50
Sovrasaturazione urinaria e cristallizzazione del calcio ossalato in soggetti normali e calcolotici 50
Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial 50
Idiopathic calcium nephrolithiasis with pure calcium oxalate composition: clinical correlates of the calcium oxalate dihydrate/monohydrate (COD/COM) stone ratio 50
Qual è l’alimentazione abituale delle donne con calcolosi calcica idiopatica? Studio italiano basato sulle linee guida INRAN. 48
What is the dietary habit of women with idiopathic calcium nephrolithiasis? An italian study based on National Institute of Research for Food and Nutrition (INRAN) recommendations. 48
Dieta e calcolosi renale 47
The relationship between urinary sodium and calcium excretion in women with idiopathic calcium nephrolithiasis and controls 46
Trials clinici nella nefrolitiasi: di che cosa abbiamo bisogno? Presente e futuro della ricerca clinica 46
Low potassium diet as a stone risk factor. 45
Role of BMI on lithogenic risk in women with idiopathic calcium nephrolithiasis and controls. 45
Polymorphisms of the calcium-sensing receptor gene and stones in primary hyperparathyroidism. 45
Prevenzione della calcolosi renale 44
Polymorphisms at the regulatory regions of the CASR gene influence stone risk in primary hyperparathyroidism 44
Ruolo del BMI sui fattori di rischio litogeno in donne con nefrolitiasi calcica idiopatica e controlli. 43
The relationship between urinary sodium and calcium excretion in women with idiopathic calcium nephrolithiasis and controls 43
Effects of body composition on bone density in healthy women and in women with idiopathic calcium nephrolithiasis. 42
La relazione tra escrezione di calcio e sodio urinari in donne con nefrolitiasi calcica idiopatica e controlli. 41
Evidenze scientifiche nel trattamento farmacologico della nefrolitiasi 40
Dietary treatment of nephrolithiasis 40
Ruolo del BMI sui fattori di rischio litogeno in donne con nefrolitiasi calcica idiopatica e controlli. 39
Polimorfismo genetico del calcium-sensing receptor e calcolosi renale nell’iperparatiroidismo primitivo 37
Hypercalciuria: low calcium diet in comparison with low sodium -low proteins-normal calcium diet. 35
Dietary treatment nephrolitiasis 33
Una dieta per ridurre l’iperossaluria moderata in pazienti con nefrolitiasi calcica idiopatica: studio pilota. 33
Role of BMI on lithogenic risk in women with idiopathic calcium nephrolithiasis and controls. 30
La relazione tra escrezione di calcio e sodio urinari in donne con nefrolitiasi calcica idiopatica e controlli 29
Totale 5.077
Categoria #
all - tutte 15.802
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.802


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.187 184 172 74 18 99 127 136 35 84 165 24 69
2020/2021593 5 70 64 5 69 12 77 31 148 23 75 14
2021/2022345 12 2 2 18 3 15 49 52 14 23 25 130
2022/20231.411 138 136 87 117 114 175 5 82 501 9 26 21
2023/2024504 37 48 31 19 37 104 21 44 28 19 48 68
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 5.077